Baguio maintains limit on visitors

The imposition of the limit on daily tourist arrivals is part of the city government’s efforts to gradually and safely revive the heavily impacted city tourism industry

BAGUIO CITY — Baguio City Mayor Benjamin Magalong stressed that the city government will maintain the limit on tourists visiting the country’s Summer Capital to only 3,000 individuals daily to prevent incidents that may trigger another surge of the coronavirus disease 2019 (Covid-19) cases.

Magalong said that while tourist arrivals in the city since 1 June 2021 have not exceeded the 3,000 daily limits, there is still a need to maintain control for the meantime.

The Baguio City mayor disclosed that daily tourist arrivals during weekdays only reached some 1,500 to 1,800, while tourist arrivals during weekends stayed at around 5,000, which was still within the prescribed limit.

He also pointed out that the imposition of the limit on daily tourist arrivals is part of the city government’s efforts to gradually and safely revive the heavily impacted city tourism industry with calculated risk, so as not to compromise the local health care system.

The city government — in partnership with stakeholders — does not want the gains of the efforts to revive the local tourism industry to be ruined by untoward incidents.

Tourists wanting to visit the city and enjoy spending their well-deserved break here are still required to register in the city’s registration platform, visita.baguio.gov.ph, and present to the quarantine control checkpoints and the central triage their QR-coded tourist pass and confirmed booking in the various accredited tourist establishments as proof of their stay in the city.

Some 374 hotels and transient houses in the city were also issued certificates of accreditation and certificates of compliance by the regional office of the tourism department that will allow them to accept tourists who are allowed to come up to the city based on existing guidelines crafted by the Inter-Agency Task Force for the Management of Emerging Infectious Diseases.